SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-048477
Filing Date
2023-09-06
Accepted
2023-09-06 17:40:13
Documents
2
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2235
2 POA DOCUMENT poa.txt EX-24 3885
  Complete submission text file 0001209191-23-048477.txt   7636
Mailing Address C/O APPLIED DNA SCIENCES, INC. 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790
Business Address
Ryan Charles S. (Reporting) CIK: 0001624830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 231240332

Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Issuer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)